Question 1
Question
Which of the following drugs are the only medications approved for the use in the treatment of Type 1 DM?
Answer
-
Pramlintide (Symlin)
-
Miglitol (Gylset)
-
Insulin
-
Pioglitazone (Actos)
Question 2
Question
Increntin hormones like GLP-1 and GIP stimulate insulin secretion in response to meals
Question 3
Question
Specify how each of the following specified areas contribute to the pathophysiology of Type 2 DM
Answer
-
decreased glucose uptake
-
decreased incretin effect
-
increased lipolysis
-
decreased insulin secretion (beta cells)
-
decreased glucose uptake
-
increased production of glucose
-
neurotransmitter dysfunction
-
increased glucagon secretion
-
increased lipolysis
-
decreased glucose uptake
-
increase production of glucose
-
increase glucose reabsorption
-
neurotransmitter dysfunction
-
increased glucose reabsorption
-
decreased incretin effect
-
increase glucagon secretion
-
neurotransmitter dysfunction
-
increased lipolysis
-
decrease glucose uptake
-
increased production of glucose
-
increased glucagon secretion (alpha cell
-
decreased glucose uptake
-
increased glucose reabsorption
-
increased lipolysis
-
decreased glucose uptake
-
increased production of glucose
-
decreased incretin effect
-
increased glucagon secretion (alpha)
-
decreased insulin secretion (beta cells)
-
increased glucagon secretion (alpha cell
-
decreased incretin effect
-
increased lipolysis
Question 4
Question
Pramlintide (Symlin) belongs to what drug class?
Question 5
Question
What type of efficacy does the following anti-diabetic drugs have?
Metformin, Sulfonyureas, TZDs, GLP-1
Answer
-
Low efficacy (< 0.5 decrease in A1C)
-
Intermediate efficacy (~0.5-1 % decrease in A1C)
-
High efficacy ( ~1-2% decrease in A1C)
Question 6
Question
What type of efficacy do the following drugs have?
SGLT2, DPP-IV, Alpha-glucosidase inhibitors
Answer
-
High efficacy (~1-2% decrease in A1C)
-
Intermediate efficacy (~0.5-1% decrease in A1C)
-
Low efficacy (< 0.5% decrease in A1C)
Question 7
Question
Of the following anti-diabetic drugs, which have the lowest efficacy in regards to the lowering of the A1C?
Answer
-
Colesvelam
-
Metformin
-
Insulins
-
Bromocriptine
Question 8
Question
[blank_start]Pramlintide (Symlin)[blank_end] has a BBW for severe HYPOglycemia
Question 9
Question
Which of the following are contraindications for Pramlintide (Symlin)?
Question 10
Question
If taking anti-diabetic drug [blank_start]Pramlintide (Symlin)[blank_end], the meal time insulin must reduced by 50%.
Question 11
Question
Pramlintide (Symlin) must be injected immediately prior to each major meal.
Question 12
Question
Miglitol (Glyset) and Acarbose (Precose) belong to what anti-diabetic drug class?
Question 13
Question
What is the MOA for the alpha-glucosidase inhibitors?
Answer
-
activation of amylin
-
activates the nuclear transcription factor PPAR-gamma
-
inhibits intestinal alpha glucosidase
-
activates GLP-1 receptors
Question 14
Question
The [blank_start]alpha-glucosidase[blank_end] drug class slows intestinal carbohydrate digestion/absorption.
Answer
-
alpha-glucosidase
-
secretagogues
-
TZDs
-
Biguanides
Question 15
Question
Alpha-glucosidase drugs must be taken with the 1st bite of each meal
Question 16
Question
Which of the following are adverse drug reactions for alpha-glucosidase class?
Question 17
Question
Contrainidcations for the [blank_start]alpha-glucosidase inhibitors[blank_end] include inflammatory bowel disease, colonic ulceration, intestinal obstruction, malabsorption, and CrCL < 25 mL/min
Question 18
Question
Hypoglycemia must be treated with what when taking an alpha glucosidase inhibitor.
Answer
-
complex carbs
-
insulins
-
simple carbohydrates
Question 19
Question
Which of the following are the mechanisms of action for the biguanides class?
Answer
-
decrease glucose production from the liver
-
closes a K(ATP) channels on beta-cell plasma membranes
-
increases insulin sensitivity in muscle
-
decrease carbohydrate uptake in gut
Question 20
Question
Which of the following are the mechanisms of action for the biguanides class?
Answer
-
closes K(ATP) channels on beta-cell plasma membranes
-
decreases glucose production form liver
-
increases insulin sensitivity in muscle
-
decreases uptake in gut
Question 21
Question
What is the physiological action of the Biguanides class?
Answer
-
increases insulin secretions
-
decreases hepatic glucose production
-
increases incretin levels
-
decreases glucagon secretion
Question 22
Question
The maximum effective does for Metformin (Glucophage) is [blank_start]2000[blank_end] mg/day
Question 23
Question
Metformin (Glucophage) has a BBW for lactic acidosis
Question 24
Question
Iodinated contrast media, unstable HF, eGFR < 30 mL/min, hepatic dysfunction, dehydration, pre-renal azotemia, hypoxic states, CKD, and acidosis are all contraindications for [blank_start]Metformin (Glucophage)[blank_end]
Question 25
Question
[blank_start]Metformin (Glucophage)[blank_end] is the first line therapy for T2DM.
Question 26
Question
Starting metformin in patients with an eGFR between 45-50 mL/min/1.73m is not recommended.
Question 27
Question
The following drugs belong to what class?
Glyburide (Micronase)
Glyburide (Micronized) - (Glynase)
Glipizide (Glucotrol)
Glimepiride (Amaryl)
Answer
-
Biguanides
-
DDP-IV
-
TZD's
-
Sulfonylureas
Question 28
Question
Closure of the K(ATP) channels on beta-cell plasma membranes is the MOA for what class(es) of drugs?
Answer
-
Sulfonylureas
-
TZDs
-
Bile Acid sequestrants
-
Meglitinides
Question 29
Question
Which of the following are ADR's for the sulfonylurea class?
Question 30
Question
[blank_start]Sulfonrylureas[blank_end] should NOT be used in elderly patients or patients with hepatic impairment
Question 31
Question
Which of the sulfonylureas can be used during pregnancy?
Answer
-
Glyburide (Micronase)
-
Glipizide (Glucotrol)
-
Glimepiride (Amaryl)
Question 32
Question
For the sulfonylurea class, 1/2 of the max dose is equal to 80% drug effectiveness
Question 33
Question
Sulfonylureas can be used in combination with insulin
Question 34
Question
Glynase can be interchanged with the drug Mirconase.
Question 35
Question
Of the sulfonylureas, [blank_start]Glipizide (Glucotrol)[blank_end] should be utilized in patients with renal impariement.
Question 36
Question
Which of the following drugs are Meglitinides?
Answer
-
Nateglinide (Starlix)
-
Pioglitazone (Actos)
-
Repaglinide (Prandin)
-
Rosiglitazone (Avandia)
Question 37
Question
Which of the following are ADR's for the Meglitinides?
Question 38
Question
[blank_start]Meglitinides[blank_end] can be antidiabetic drug that can be reccommended for patients who are meal skippers.
Question 39
Question
Repaglinide (Prandin) is contraindicated with Gemfibrozil
Question 40
Question
Which drugs listed below belong the Thiazolidinediones (TZDs) class?
Answer
-
Sitagliptin (Januvia)
-
Linagliptin (Tradjenta)
-
Pioglitazone (Actos)
-
Rosiglitazone (Avandia)
Question 41
Question
What is the MOA for the Thiazolidinediones class?
Answer
-
closure of the K(ATP) channels on the beta-cell membranes
-
activates dopaminergic receptors
-
activates GLP-1 receptors
-
activates the nuclear transcription factor PPAR-gamma
Question 42
Question
What is the physiological action for the TZD class?
Answer
-
increases insulin secretion
-
increases insulin sensitivity in the skeletal muscle, adipocytes, and liver
-
decreases hepatic glucose production
Question 43
Question
[blank_start]TZDs[blank_end] have a BBW warning for heart failure
Answer
-
TZDs
-
Meglitinides
-
DPP-IV inhibitors
-
Bile Acid Sequestrants
Question 44
Question
Select the ADRs of the TZD class
Question 45
Question
Which patient should not take TZDs for their diabetes?
Question 46
Question
Of the TZD drugs, which has an improved lipid profile?
Answer
-
Pioglitazone (Actos)
-
Rosiglitazone (Avandia)
Question 47
Question
TZDs can be used in combination with Metformin
Question 48
Question
[blank_start]Colesevelam (Welchol)[blank_end] is a bile acid sequestrant
Question 49
Question
Binds bile acids in intestinal tract, increasing hepatic bile acid production and activates the farnesoid X receptor (FXR) in the liver is the MOA for what drug class?
Answer
-
Dopamine agonist
-
Bile acid sequestrant
-
DPP-IV inhibitors
-
Biguanides
Question 50
Question
Indicate the physiological actions of the bile acid sequestrant class?
Answer
-
Decreases hepatic glucose production
-
increases incretin levels
-
increases insulin sensitivity
-
activates GLP-1 receptors
Question 51
Question
Which of the following are ADR's for bile acid sequestrant?
Question 52
Question
Bowel obstructions, TG > 500 mg/dL, and history of hypertriglyceridemia-induced pancreatitis are contraindications for ....
Answer
-
Dopamine agonist
-
Bile acid sequestrant
-
DPP-IV
-
SGLT-2
Question 53
Question
Colesevelam (Welchol) can be approved for monotherapy
Question 54
Question
Bromocriptine (Cycloset) belongs to what anti-diabetic drug class?
Answer
-
Bile acid sequestrant
-
SGLT-2
-
Dopamine agonist
-
GLP-1
Question 55
Question
What is the MOA for Bromocriptine (Cycloset)?
Answer
-
inhibits DPP-IV activity
-
activates GLP-1 receptors
-
inhibits SGLT-2 in the proximal tubule
-
activates dopaminergic receptors
Question 56
Question
What are the physiological actions for the Dopamine agonist class?
Answer
-
modulates HYPOthalamic regulation of metabolism
-
decrease hepatic glucose production
-
increased incretin levels
-
increased insulin sensitivity
Question 57
Question
Postural hypotension, headache, fatigue, hallucinations, psychotic disorder, pleural effusion, pulmonary fibrosis, and GI ulcers are the ADR's for what drug?
Answer
-
Colesevelam (Welchol)
-
Bromocriptine (Cycloset)
-
Sitagliptin (Januvia)
-
Liraglutide (Victoza)
Question 58
Question
Which of the following are contraindications for the Bromocriptine (Cycloset)?
Question 59
Question
Bromocriptine (Cycloset) is not approved for monotherapy.
Question 60
Question
What drug class do the following drugs belong to?
Sitagliptin (Januvia)
Saxagliptin (Onglyza)
Linagliptin (Tradjenta)
Alogliptin (Nesina)
Answer
-
DPP-IV
-
SGLT2 inhibitors
-
Dopamine agonist
-
GLP-1 agonist
Question 61
Question
Inhibits DPP-IV activity, increasing postprandial active incretin concentrations is the MOA for what drug class?
Answer
-
GLP-1
-
TZDs
-
Biguanides
-
DPP-IV inhibitors
Question 62
Question
What are the physiological actions for the DPP-IV inhibitors? (select all that apply)
Answer
-
increases insulin secretion (glucose-dependent)
-
increase renal excretion of glucose
-
decrease glucagon secretion (glucose-dependent)
-
slows gastric emptying
Question 63
Question
Of the DPP-IV inhibitors, which one does not need to be adjusted in renal and hepatic impairment?
Answer
-
Alogliptin (Nesina)
-
Linagliptin (Tradjenta)
-
Saxagliptin (Onglyza)
-
Sitagliptin (Januvia)
Question 64
Question
ADR's for DPP-IV's include which of the following
Question 65
Question
FDA warns that [blank_start]DPP-4 inhibitors[blank_end] may cause severe joint pain that can be severe or diabiling
Answer
-
DPP-4 inhibitors
-
SGLT-2
-
GLP-1 inhibitors
-
TZDs
Question 66
Question
Which of the DPP-IV inhibitors can cause heart failure?
Answer
-
Sitagliptin (Januvia)
-
Saxagliptin (Onglyza)
-
Linagliptin (Tradjenta)
-
Alogliptin (Nesina)
Question 67
Question
The following drugs belong to what drug class?
Exenatide (Byetta)
Liraglutide (Victoza)
Abiglutide (Tanzeum)
Dulagultide (Trulicity)
Answer
-
GLP-1 agonist
-
TZDs
-
DPP-IV
-
SGLT-2
Question 68
Question
Select the physiological actions of the GLP-1 class
Question 69
Question
Of the GLP-1 agonist, which one can not be used if the CrCL is < 30 mL/min?
Answer
-
Exenatide (Byetta)
-
Liraglutide (Victoza)
-
Abiglutide (Tanzeum)
-
Dulaglutide (Trulicity)
Question 70
Question
Of the GLP-1 inhibitors, which ones have a BBW warning for thyroid carcinoma?
Answer
-
Exenatide (Byetta)
-
Liraglutide (Victoza)
-
Abiglutide (Tanzeum)
-
Dulaglutide (Trulicity)
Question 71
Question
History of pancreatitis, gastroparesis or GI disease, and caution in renal impairment are all contrainidcations for the [blank_start]GLP-1 agontist[blank_end]
Answer
-
GLP-1 agonist
-
DPP-IV
-
TZDs
-
SGLT-2
Question 72
Question
The following drugs belong to what drug class?
Canagliflozin (Invokana)
Dapagliflozin (Farxiga)
Empagliflozin (Jardiance)
Answer
-
SGLT-2 inhibitors
-
DPP-IV
-
Biguanides
-
Meglitinides
Question 73
Question
Which of the following are ADR's for the SGLT-2 inhibitor drug class?
Question 74
Question
Hypovolemia must be corrected prior to starting a SGLT-2 inhibitor
Question 75
Question
Increased risk of bladder cancer and bone fracture with [blank_start]Dapagliflozin (Farxiga)[blank_end]
Question 76
Question
[blank_start]Empagliflozin (Jardiance)[blank_end] is assocaited with an increase in CV events
Question 77
Question
[blank_start]Canagliflozin (Invokana)[blank_end] may be associated with an increase in lower extremity amputations
Question 78
Question
Which drug classes target fasting BG only!
Answer
-
Biguanides
-
TZDs
-
SGLT-2
-
Amylinomimetics
Question 79
Question
Which drug classes targets post-prandial blood glucose only!
Question 80
Question
What drug classes target BOTH fasting and postprandial BG levels?
Answer
-
Sulfonylureas
-
TZDs
-
SGLT-2 inhibitors
-
Bile acid sequestrants
Question 81
Question
GLP-1 agonist, Metformin, SGLT-2, Amylinmimetics all cause [blank_start]weight loss[blank_end]
Answer
-
weight loss
-
weight gain
-
weight neutral
Question 82
Question
Metformin, alpha-glucosidase inhibitors, DPP-IV inhibitors all cause [blank_start]weight gain[blank_end]
Answer
-
weight gain
-
weight loss
-
weight neutral
Question 83
Question
Suflonylureas, Meglitinides, insulins, and TZDs all cause [blank_start]weight loss[blank_end]
Answer
-
weight loss
-
weight gain
-
weight neutral
Question 84
Question
Which drug classes are high cost agents?
Answer
-
GLP-1
-
SGLT-2
-
DPP-IV
-
Insulins
-
Metformin
-
Sulfonylureas
-
TZDs
Question 85
Question
Which drugs classes are low cost agents?
Answer
-
Metformin
-
Sulfonylureas
-
DPP-IV
-
TZDs
-
GLP-1
-
SGLT-2